Company intelligence / Profile preview

Veridien

St. Petersburg, Florida, USA
Ownership
Private
Development stage
Other
01

Overview

Veridien Corporation was a life sciences company specializing in the development and commercialization of antimicrobial and infection control products. The company's flagship product line, marketed under the brand name Viraguard, included hospital-grade disinfectants, antiseptic hand sanitizers, and wipes designed to eliminate a broad spectrum of pathogens, including bacteria and viruses. Veridien's offerings were primarily targeted at healthcare facilities, emergency services, and the consumer health sector to prevent the spread of infectious diseases. Although the company was once publicly traded and achieved commercial status for its core technologies, it has since become inactive in the biotechnology sector.

Therapeutic areas
Infectious Diseases
Modalities
Small molecule
Industry
Consumable Medical Devices

Beyond the preview

Go deeper on Veridien.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Veridien.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call